Application value of CEUS LI-RADS in hepatic focal lesions in patients without hepatocellular carcinoma at high risk factors

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100045579

Enrollment

Unknown

Registered

2021-04-19

Start date

2022-05-01

Completion date

Unknown

Last updated

2021-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hepatocellular carcinoma

Interventions

Gold Standard:Postoperative pathology or follow-up imaging (CT/MRI) results.

Index test:Contrast-enhanced&#32

ultrasound&#32

imaging&#32

of&#32

the&#32

liver.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. The patient showed focal liver lesions on routine ultrasound examination; 2. Non-HCC high-risk patients (hepatitis B, cirrhosis).

Exclusion criteria

Exclusion criteria: Patients who do not sign informed consent.

Design outcomes

Primary

Measure	Time frame
Nodule size;Clarify;Consistency;SEN, SPE, ACC, AUC of ROC, PPV, NPV;	—

Countries

China

Contacts

Public ContactHuang Pintong

The Second Affiliated Hospital of Zhejiang University

huangpintong@126.com+86 18857168333

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026